A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis

MLA

Toshihiko Hibino, et al. “A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis.” Rheumatology and Therapy, vol. 7, no. 1, Dec. 2019, pp. 149–63. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....144d39f4ca6c70fbc856e0c3461171e9&authtype=sso&custid=ns315887.

APA

Toshihiko Hibino, Juan Sánchez-Bursón, E. Drescher, Naoyuki Kamatani, Chirag Shah, Yoshiya Tanaka, Dhananjay Bakhle, Hisashi Yamanaka, Manfred Rettenbacher, Girish Bhatia, & Snehal Ameet Gadve. (2019). A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis. Rheumatology and Therapy, 7(1), 149–163.

Chicago

Toshihiko Hibino, Juan Sánchez-Bursón, E. Drescher, Naoyuki Kamatani, Chirag Shah, Yoshiya Tanaka, Dhananjay Bakhle, et al. 2019. “A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis.” Rheumatology and Therapy 7 (1): 149–63. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....144d39f4ca6c70fbc856e0c3461171e9&authtype=sso&custid=ns315887.